[ Price : $8.95]
Sources say Novartis has moved creative advertising work for Diovan from Deutsch to Hill, Holliday.[ Price : $8.95]
A joint FDA advisory panel reviews Sanofi-Aventis controversial antibiotic Ketek next month to assess its overall benefit-to-risk ...[ Price : $8.95]
Roche revises the precautions on its influenza drug Tamiflu based on reports from Japan about self-injury and delirium.[ Price : $8.95]
FDA extends its review time for Novartis Galvus for three months to study additional clinical data.[ Price : $8.95]
FDA allows ReGen to submit a new 510(k) for its collagen scaffold device with modified indications suggested by the company.[ Price : $8.95]
Consulting editor John Scharmann reviews FDAs hiring of a generic drug industry legislative expert in its Office of Legislation an...[ Price : $8.95]
Dendreon completes its rolling BLA submission for its Provenge, an active cellular immunotherapy for hormone-refractory prostate c...[ Price : $8.95]
FDA says NicOx does not need to submit a large clinical cardiovascular outcomes study with its naproxcinod NDA.